Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years

Olliaro, P. L., Kuesel, A. C., Halleux, C. M., Sullivan, M., & Reeder, J. C. (2018). Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years. PLoS Neglected Tropical Diseases, 12(11). https://doi.org/10.1371/journal.pntd.0006837